POPS RICHARD F has filed 49 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 88843 shares of Alkermes plc. ($ALKS) on March 02, 2026.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | A | Restricted Stock Unit Award | 88843 | $0.00 | 88,843.0000 | 168,510,000 | 9999.99% | 0.05% |
| Feb. 5, 2026 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | A | Ordinary Shares | 149580 | $0.00 | 1,439,970.0000 | 168,510,000 | 11.59% | 0.09% |
| Feb. 5, 2026 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | F | Ordinary Shares | 62230 | $33.55 | 1,377,740.0000 | 168,510,000 | 4.32% | 0.04% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Restricted Stock Unit | 2869 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Common Stock | 2869 | $0.00 | 34,480.0000 | 103,700,000 | 9.08% | 0.00% |
| Feb. 19, 2025 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | A | Employee Stock Option (Right to Buy) | 293921 | $0.00 | 293,921.0000 | 169,198,000 | 9999.99% | 0.17% |
| Feb. 6, 2025 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | F | Ordinary Shares | 79925 | $31.39 | 1,290,390.0000 | 169,198,000 | 5.83% | 0.05% |
| Feb. 6, 2025 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | A | Ordinary Shares | 190640 | $0.00 | 1,370,315.0000 | 169,198,000 | 16.16% | 0.11% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | A | Restricted Stock Unit | 2869 | $0.00 | 2,869.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Restricted Stock Unit | 4199 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Common Stock | 4199 | $0.00 | 33,711.0000 | 101,000,000 | 14.23% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | S | Common Stock | 2100 | $141.84 | 31,611.0000 | 101,000,000 | 6.23% | 0.00% |
| March 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 23200 | $42.76 | 0.0000 | 101,000,000 | 100.00% | 0.02% |
| March 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Common Stock | 23200 | $42.76 | 52,712.0000 | 101,000,000 | 78.61% | 0.02% |
| March 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | S | Common Stock | 23200 | $140.33 | 29,512.0000 | 101,000,000 | 44.01% | 0.02% |
| March 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Common Stock | 1700 | $42.76 | 31,212.0000 | 101,000,000 | 5.76% | 0.00% |
| March 11, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | S | Common Stock | 100 | $140.00 | 29,512.0000 | 101,000,000 | 0.34% | 0.00% |
| March 11, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Common Stock | 100 | $42.76 | 29,612.0000 | 101,000,000 | 0.34% | 0.00% |
| March 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | S | Common Stock | 1700 | $140.05 | 29,512.0000 | 101,000,000 | 5.45% | 0.00% |
| March 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 1700 | $42.76 | 23,300.0000 | 101,000,000 | 6.80% | 0.00% |
| March 11, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 100 | $42.76 | 23,200.0000 | 101,000,000 | 0.43% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 6843 | $19.34 | 349,030.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 4599 | $46.24 | 234,599.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 3999 | $69.83 | 203,999.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 5999 | $31.64 | 305,999.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 3999 | $53.50 | 203,999.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 5899 | $65.94 | 300,899.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 2419 | $31.93 | 123,419.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 7644 | $31.93 | 389,844.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 7168 | $20.03 | 365,634.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 5980 | $24.59 | 305,024.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | J | Employee Stock Option (Right to Buy) | 5697 | $26.82 | 290,570.0000 | 163,742,000 | 2.00% | 0.00% |
| Feb. 26, 2024 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | A | Employee Stock Option (Right to Buy) | 274328 | $0.00 | 274,328.0000 | 169,730,000 | 9999.99% | 0.16% |
| Feb. 20, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | S | Common Stock | 15000 | $132.47 | 29,512.0000 | 101,000,000 | 33.70% | 0.01% |
| Feb. 20, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 15000 | $12.98 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| Feb. 20, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Common Stock | 15000 | $12.98 | 44,512.0000 | 101,000,000 | 50.83% | 0.01% |
| Feb. 8, 2024 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | A | Ordinary Shares | 218551 | $0.00 | 1,271,432.0000 | 169,730,000 | 20.76% | 0.13% |
| Feb. 8, 2024 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | F | Ordinary Shares | 91757 | $26.77 | 1,179,675.0000 | 169,730,000 | 7.22% | 0.05% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | A | Restricted Stock Unit | 4199 | $0.00 | 4,199.0000 | 98,900,000 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | A | Employee Stock Option (Right to Buy) | 284873 | $0.00 | 284,873.0000 | 163,742,000 | 9999.99% | 0.17% |
| Feb. 21, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | M | Restricted Stock Unit Award | 32400 | $0.00 | 0.0000 | 163,742,000 | 100.00% | 0.02% |
| Feb. 21, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | M | Ordinary Shares | 32400 | $0.00 | 1,067,267.0000 | 163,742,000 | 3.13% | 0.02% |
| Feb. 21, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | F | Ordinary Shares | 14386 | $27.77 | 1,052,881.0000 | 163,742,000 | 1.35% | 0.01% |
| Feb. 20, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | F | Ordinary Shares | 53145 | $28.07 | 1,034,867.0000 | 163,742,000 | 4.88% | 0.03% |
| Feb. 20, 2023 | Alkermes plc. | $ALKS | POPS RICHARD F | Director and CEO, Alkermes plc | A | Ordinary Shares | 119713 | $0.00 | 1,088,012.0000 | 163,742,000 | 12.36% | 0.07% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Common Stock | 15000 | $12.71 | 44,512.0000 | 98,900,000 | 50.83% | 0.02% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | S | Common Stock | 15000 | $119.20 | 29,512.0000 | 98,900,000 | 33.70% | 0.02% |
| Jan. 3, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | POPS RICHARD F | Director | M | Non-Qualified Stock Option | 15000 | $12.71 | 0.0000 | 98,900,000 | 100.00% | 0.02% |